Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.066 AUD | +3.12% | +8.20% | -7.04% |
04-04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
02-27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-7.04% | 12.2M | |
-4.06% | 86.13B | |
+1.32% | 39.82B | |
+56.40% | 25.23B | |
-15.00% | 15.36B | |
-9.14% | 11.95B | |
-16.54% | 11.6B | |
-43.00% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm's Strategic Partner Secures Grant Funding from the Australian Government